Neuland Laboratories · NSE: NEULANDLAB · BSE: 524558
Q2 FY23 results · Jul–Sep 2022
Neuland Laboratories reported revenue from operations of ₹293.71 crore (up 13.9% from Q2 FY22) and net profit of ₹38.46 crore (up 88.8% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 293.71 | 257.85 | +13.9% | 221.17 | +32.8% |
| Other income | 0.24 | 0.29 | −16.5% | 0.51 | −53.3% |
| Total income | 293.94 | 258.13 | +13.9% | 221.68 | +32.6% |
| Profit before tax | 53.19 | 27.58 | +92.9% | 13.46 | +295.2% |
| Net profit for the period | 38.46 | 20.37 | +88.8% | 9.97 | +285.9% |
| EPS, basic (₹) | 29.97 | 15.88 | +88.7% | 7.77 | +285.7% |
| Net margin (%) | 13.1 | 7.9 | 4.5 |
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 293.71 | 257.85 | +13.9% | 221.17 | +32.8% |
| Other income | 0.24 | 0.29 | −16.5% | 0.51 | −53.3% |
| Total income | 293.94 | 258.13 | +13.9% | 221.68 | +32.6% |
| Profit before tax | 53.06 | 27.53 | +92.7% | 13.33 | +298.0% |
| Net profit for the period | 38.33 | 20.33 | +88.6% | 9.84 | +289.5% |
| EPS, basic (₹) | 29.88 | 15.84 | +88.6% | 7.67 | +289.6% |
| Net margin (%) | 13.1 | 7.9 | 4.4 |
Consolidated
- Filed with BSE
- 11 Nov 2022, 10:40 IST
- Board meeting
- 10 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Nov 2022, 10:40 IST
- Board meeting
- 10 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE